antithrombogenic

the medical device is coated with an antithrombogenic polymer to prevent blood clotting during surgery.

new antithrombogenic agents are being developed to reduce the risk of stroke in high-risk patients.

the antithrombogenic properties of this biomaterial make it ideal for cardiovascular implants and prosthetic devices.

researchers have discovered a novel antithrombogenic coating that significantly extends the lifespan of artificial heart valves.

the antithrombogenic activity of this compound was demonstrated through extensive laboratory testing and clinical validation.

surface modification with antithrombogenic molecules effectively reduces platelet adhesion and subsequent clot formation.

the hospital has implemented comprehensive antithrombogenic protocols for all invasive cardiovascular procedures.

advanced antithrombogenic materials are revolutionizing the design of blood-contacting medical devices such as catheters.

clinical trials are currently evaluating the efficacy of next-generation antithrombogenic drugs for treating deep vein thrombosis.

the antithrombogenic surface treatment applied to coronary stents has dramatically reduced restenosis rates in patients.

nanoparticles engineered with antithrombogenic properties offer promising applications in targeted drug delivery systems.

the cardiovascular surgeon recommended antithrombogenic therapy following the successful implantation of the ventricular assist device.